Iron-Deficiency Anemia in Chronic Kidney Disease: A Literature Review of Its Pathophysiology, Diagnosis, and Management
Related Experiment Video
Updated: May 27, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Saba Kazmi1, Viktoriia Zarovniaeva2, Kimberly Cortez Perez1
1Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Abstract:
Anemia is a prevalent complication of chronic kidney disease (CKD) and is associated with increased mortality and reduced health-related quality of life. The iron-rich protein hemoglobin, which the body utilizes to carry oxygen, deteriorates in anemia. Because hemoglobin is a protein that contains iron, disturbances in iron homeostasis can lead to iron-deficiency anemia (IDA). CKD frequently results in anemia, which is linked to a poor prognosis. Nevertheless, whether anemia per se or other comorbidities are the reason for this connection remains unclear. Uncertainty surrounds whether distinct forms of IDA can forecast CKD outcomes. Physicians, nurse practitioners, physician assistants, and registered nurses work as a team to manage anemia in patients with CKD. Individuals with CKD can benefit from the involvement of different specialties along the treatment continuum, and dietitians/nutritionists can play a significant role in enhancing management through multidisciplinary care. This literature review aims to deliver a comprehensive overview of IDA in CKD, concentrating on its diagnosis. It addresses the pathophysiology, complications associated with iron deficiency, and the available diagnostic tests for IDA in CKD. Furthermore, we analyze the literature that has contributed to developing current practice guidelines for treating IDA in CKD and encouraging multidisciplinary team collaboration in managing IDA in CKD.
Related Concept Videos
Hormonal Regulation
Kidney Structure
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Nephrons

